From the Fernández-Vega Ophthalmological Institute (Alfonso, Lisa, Fernández-Vega Cueto, Poo-López, Fernández-Vega) and the Surgery Department (Alfonso, Fernández-Vega), School of Medicine, University of Oviedo, Oviedo, and the Optics II Department (Madrid-Costa), Faculty of Optics and Optometry, Universidad Complutense de Madrid, Madrid, Spain.
From the Fernández-Vega Ophthalmological Institute (Alfonso, Lisa, Fernández-Vega Cueto, Poo-López, Fernández-Vega) and the Surgery Department (Alfonso, Fernández-Vega), School of Medicine, University of Oviedo, Oviedo, and the Optics II Department (Madrid-Costa), Faculty of Optics and Optometry, Universidad Complutense de Madrid, Madrid, Spain.
J Cataract Refract Surg. 2017 Feb;43(2):246-254. doi: 10.1016/j.jcrs.2016.11.044.
To evaluate the efficacy, safety, predictability, and stability of sequential Ferrara intrastromal corneal ring segment (ICRS) and intraocular lens (IOL) implantation in patients with keratoconus and cataract.
Fernández-Vega Ophthalmological Institute, Oviedo, Spain.
Retrospective case series.
This study comprised patients with keratoconus and cataract who had ICRS implantation followed 6 months later by IOL implantation. The uncorrected (UDVA) and corrected (CDVA) distance visual acuities and residual refractive errors, analyzed using vector analysis, were recorded preoperatively, 6 months after ICRS implantation, 6 months after IOL implantation, and 3 years and 5 years thereafter.
Seventy eyes of 47 patients were studied. The mean UDVA was 1.08 logMAR ± 0.24 (SD) preoperatively, 0.95 ± 0.31 logMAR 6 months after ICRS implantation (P = .03), and 0.44 ± 0.29 logMAR 6 months after IOL implantation (P < .0001). The mean CDVA changed from 0.35 ± 0.23 logMAR before surgery to 0.28 ± 0.22 logMAR 6 months after ICRS implantation (P < .0001) and to 0.11 ± 0.16 logMAR 6 months after IOL implantation (P < .0001). The UDVA and CDVA were stable over the period after the second procedure (P > .05). The spherical equivalent (SE) and the refractive cylinder declined steeply after IOL implantation (P < .001) and then were stable (P > .05).
Sequential ICRS and IOL implantation provided good visual and refractive outcomes and was an effective, safe, predictable, and stable procedure for the treatment of patients with keratoconus and cataract.
评估序列 Ferrara 基质内角膜环段(ICRS)和人工晶状体(IOL)植入治疗圆锥角膜合并白内障患者的疗效、安全性、可预测性和稳定性。
西班牙奥维耶多费尔南德斯-维加眼科研究所。
回顾性病例系列。
本研究纳入了接受 ICRS 植入术且 6 个月后接受 IOL 植入术的圆锥角膜合并白内障患者。记录术前、ICRS 植入术后 6 个月、IOL 植入术后 6 个月以及术后 3 年和 5 年的未矫正(UDVA)和矫正(CDVA)远视力和残余屈光误差,并采用向量分析进行分析。
47 例患者的 70 只眼纳入研究。术前平均 UDVA 为 1.08 对数视力(logMAR)±0.24(标准差),ICRS 植入术后 6 个月为 0.95±0.31 logMAR(P=0.03),IOL 植入术后 6 个月为 0.44±0.29 logMAR(P<0.0001)。平均 CDVA 从术前的 0.35±0.23 logMAR 变为 ICRS 植入术后 6 个月的 0.28±0.22 logMAR(P<0.0001),再变为 IOL 植入术后 6 个月的 0.11±0.16 logMAR(P<0.0001)。第二次手术后,UDVA 和 CDVA 均保持稳定(P>0.05)。IOL 植入术后球镜(SE)和屈光柱显著下降(P<0.001),随后稳定(P>0.05)。
序列 ICRS 和 IOL 植入为圆锥角膜合并白内障患者提供了良好的视力和屈光结果,是一种有效、安全、可预测和稳定的治疗方法。